MedPath

COVID-19 and Acute Invasive Fungal Rhinosinusitis

Completed
Conditions
Covid19
Interventions
Diagnostic Test: Fungal rhinosinusitis
Registration Number
NCT04809480
Lead Sponsor
Al-Azhar University
Brief Summary

Data for acute invasive rhinosinusitis was obtained from the Otorhinolaryngology departments at our tertiary hospital at the period from January 2017 to December 2020. Then the risk factors of comorbid diseases and fungal types between post-Covid-19 and non-Covid-19 groups regarding the incidence of invasive rhinosinusitis are compared.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Patients of any age and sex. invasive rhinosinusoitis diagnosis based on clinical , endoscopic diagnosis
  • Positive findings for acute sinusitis on sinus computed tomography (CT) scan in addition to fungal determination by histopathological examination of specimen of affected tissues for detection of the type of fungi.
  • Positive PCR was confirmed from the patient's files at the isolation hospitals for COVID 19 group.
Exclusion Criteria
  • Patients who completed management outside our hospital

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Non-COVID19 patientsFungal rhinosinusitisAll acute invasive fungal rhinosinusitis patients managed in our hospital from January 2017 up to February 2020
COVID19 patientsFungal rhinosinusitisAll acute invasive fungal rhinosinusitis patients managed in our hospital from February 2020 up to December 2020 with positive COVID19 PCR test
Primary Outcome Measures
NameTimeMethod
Fungus detection2 weeks

Culture and microscopic examination by the light microscope to examine the different types of the fungi using hematoxylin \& eosin stain and Periodic acid-Schiff stain which is positive in fungi

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath